particle FR940405-1-00052 1 67
deposition FR940405-1-00052 1 68
could FR940405-1-00052 1 69
occur FR940405-1-00052 1 70
, FR940405-1-00052 38 71 83 89 135 137 148 205 230 240 242 244 249 251 278 422 428 539 638 640 642 644 682 701 720 773 784 786 788 863 896 937 949 951 953 1011 1018 1026 1090
decreasing FR940405-1-00052 1 72
exposure FR940405-1-00052 8 73 88 309 323 1127 1136 1149 1172
to FR940405-1-00052 19 74 116 175 190 254 314 376 433 470 519 543 582 602 735 885 1035 1049 1083 1124
the FR940405-1-00052 54 75 86 100 107 125 141 155 179 221 234 279 335 364 367 423 452 479 499 508 521 533 546 550 554 609 615 675 686 694 697 750 753 757 792 819 829 847 869 912 957 974 986 1023 1042 1078 1100 1114 1125 1132 1135 1138 1163 1167 1171
lung FR940405-1-00052 9 76 97 224 290 336 353 370 397 406
. FR940405-1-00052 59 77 106 130 163 197 200 228 233 264 285 302 317 339 360 363 388 399 420 437 457 490 512 526 553 568 593 596 620 623 636 655 659 662 696 711 718 728 739 743 746 769 808 843 861 891 900 903 931 968 996 1009 1041 1063 1067 1070 1086 1113 1137 1173
these FR940405-1-00052 6 78 150 461 1045 1061 1117
anatomical FR940405-1-00052 1 79
and FR940405-1-00052 23 80 157 167 188 245 262 291 472 475 488 504 626 690 723 789 827 839 877 954 984 992 1099 1128
physiological FR940405-1-00052 1 81
differences FR940405-1-00052 1 82
aside FR940405-1-00052 1 84
from FR940405-1-00052 12 85 178 268 631 685 693 702 713 756 797 923 1044
subchronic FR940405-1-00052 1 87
may FR940405-1-00052 2 90 133
partially FR940405-1-00052 1 91
account FR940405-1-00052 1 92
for FR940405-1-00052 6 93 124 192 559 670 1154
absence FR940405-1-00052 1 94
of FR940405-1-00052 39 95 109 127 140 144 154 160 182 208 223 266 310 320 352 369 396 405 454 460 478 498 507 523 529 535 565 577 628 674 752 794 915 959 1080 1103 1116 1134 1142 1166
any FR940405-1-00052 1 96
tumors FR940405-1-00052 2 98 166
in FR940405-1-00052 44 99 171 186 201 212 220 237 259 282 289 327 355 372 415 430 451 585 605 651 770 779 791 805 818 828 853 857 868 888 892 939 944 956 965 973 985 1001 1005 1022 1038 1060 1077 1087 1158
study FR940405-1-00052 6 101 351 365 772 941 1089
by FR940405-1-00052 5 102 272 298 348 764
coggins FR940405-1-00052 1 103
et FR940405-1-00052 5 104 657 741 898 1065
al FR940405-1-00052 5 105 658 742 899 1066
application FR940405-1-00052 1 108
cigarette FR940405-1-00052 10 110 146 176 524 536 574 681 760 917 927
smoke FR940405-1-00052 34 111 147 162 181 210 239 316 322 342 387 525 537 552 570 575 598 610 625 668 688 707 725 755 775 814 849 865 918 936 1017 1053 1059 1085 1102
condensate FR940405-1-00052 5 112 211 538 576 919
( FR940405-1-00052 9 113 275 408 761 920 928 978 1144 1157
csc FR940405-1-00052 7 114 131 921 938 969 997 1019
) FR940405-1-00052 9 115 277 413 763 922 930 980 1146 1161
mouse FR940405-1-00052 1 117
skin FR940405-1-00052 3 118 165 191
is FR940405-1-00052 3 119 270 345
a FR940405-1-00052 7 120 213 217 286 349 391 606
widely FR940405-1-00052 1 121
employed FR940405-1-00052 2 122 557
assay FR940405-1-00052 8 123 558 826 836 874 983 989 1025
evaluation FR940405-1-00052 1 126
carcinogenic FR940405-1-00052 2 128 142
potential FR940405-1-00052 2 129 455
assays FR940405-1-00052 3 132 768 1062
not FR940405-1-00052 4 134 333 386 709
however FR940405-1-00052 4 136 421 862 1010
reveal FR940405-1-00052 1 138
all FR940405-1-00052 3 139 318 1143
activity FR940405-1-00052 10 143 295 330 338 561 650 738 914 1076 1153
actual FR940405-1-00052 1 145
because FR940405-1-00052 3 149 466 477
condensates FR940405-1-00052 2 151 712
lack FR940405-1-00052 1 152
most FR940405-1-00052 3 153 528 555
volatile FR940405-1-00052 2 156 699
semie FR940405-1-00052 1 158
components FR940405-1-00052 1 159
whole FR940405-1-00052 3 161 551 569
benign FR940405-1-00052 1 164
carcinomas FR940405-1-00052 2 168 225
were FR940405-1-00052 2 169 1092
seen FR940405-1-00052 3 170 933 1014
swissicr FR940405-1-00052 1 172
mice FR940405-1-00052 1 173
exposed FR940405-1-00052 3 174 375 1082
tar FR940405-1-00052 1 177
sidestream FR940405-1-00052 17 180 597 624 667 687 706 724 754 774 813 848 864 935 1016 1052 1084 1101
nonfilter FR940405-1-00052 1 183
cigarettes FR940405-1-00052 3 184 1091 1105
suspended FR940405-1-00052 1 185
acetone FR940405-1-00052 1 187
applied FR940405-1-00052 1 189
15 FR940405-1-00052 1 193
months FR940405-1-00052 1 194
[ FR940405-1-00052 13 195 226 300 358 591 618 634 660 716 726 744 901 1068
ex FR940405-1-00052 10 196 301 359 592 619 661 727 745 902 1069
4327 FR940405-1-00052 1 198
] FR940405-1-00052 13 199 232 304 362 595 622 646 664 722 730 748 905 1072
lifetime FR940405-1-00052 1 202
rat FR940405-1-00052 4 203 799 859 1007
studies FR940405-1-00052 3 204 895 1047
intrapulmonary FR940405-1-00052 1 206
implants FR940405-1-00052 1 207
mainstream FR940405-1-00052 5 209 704 715 916 1058
lipid FR940405-1-00052 1 214
vehicle FR940405-1-00052 1 215
caused FR940405-1-00052 2 216 324
dosedependent FR940405-1-00052 1 218
increase FR940405-1-00052 3 219 288 326
incidence FR940405-1-00052 3 222 368 395
exs FR940405-1-00052 3 227 635 717
475 FR940405-1-00052 1 229
4289 FR940405-1-00052 1 231
polyamines FR940405-1-00052 1 235
contained FR940405-1-00052 1 236
tobacco FR940405-1-00052 3 238 341 578
spermidine FR940405-1-00052 1 241
spermine FR940405-1-00052 1 243
their FR940405-1-00052 4 246 377 771 893
diamine FR940405-1-00052 1 247
precursor FR940405-1-00052 1 248
putrescine FR940405-1-00052 2 250 267
are FR940405-1-00052 5 252 468 473 502 510
believed FR940405-1-00052 1 253
have FR940405-1-00052 9 255 390 443 516 531 541 579 731 736
an FR940405-1-00052 4 256 306 402 448
essential FR940405-1-00052 1 257
role FR940405-1-00052 1 258
cellular FR940405-1-00052 1 260
proliferation FR940405-1-00052 1 261
differentiation FR940405-1-00052 1 263
formation FR940405-1-00052 1 265
ornithine FR940405-1-00052 3 269 273 293
catalyzed FR940405-1-00052 1 271
decarboxylase FR940405-1-00052 2 274 294
odc FR940405-1-00052 3 276 329 337
ratelimiting FR940405-1-00052 1 280
enzyme FR940405-1-00052 1 281
polyamine FR940405-1-00052 1 283
biosynthesis FR940405-1-00052 1 284
significant FR940405-1-00052 3 287 325 1074
trachea FR940405-1-00052 2 292 328
was FR940405-1-00052 17 296 401 425 599 611 708 850 866 883 942 963 970 998 1020 1033 1106 1119
observed FR940405-1-00052 3 297 414 906
olsen FR940405-1-00052 1 299
4245 FR940405-1-00052 1 303
after FR940405-1-00052 3 305 1131 1148
eight FR940405-1-00052 1 307
week FR940405-1-00052 1 308
male FR940405-1-00052 1 311
spraguedawley FR940405-1-00052 1 312
rats FR940405-1-00052 6 313 1081 1112 1118 1147 1169
ms FR940405-1-00052 1 315
dilutions FR940405-1-00052 1 319
ss FR940405-1-00052 2 321 1126
but FR940405-1-00052 5 331 801 881 962 1032
did FR940405-1-00052 2 332 385
influence FR940405-1-00052 1 334
environmental FR940405-1-00052 1 340
induced FR940405-1-00052 1 343
carcinogenicity FR940405-1-00052 2 344 489
also FR940405-1-00052 7 346 476 600 647 732 810 971
supported FR940405-1-00052 1 347
casecontrol FR940405-1-00052 1 350
cancer FR940405-1-00052 4 354 371 398 407
pet FR940405-1-00052 2 356 373
dogs FR940405-1-00052 4 357 374 382 389
4259 FR940405-1-00052 1 361
compared FR940405-1-00052 1 366
owners FR940405-1-00052 3 378 384 419
' FR940405-1-00052 1 379
smoking FR940405-1-00052 2 380 418
versus FR940405-1-00052 1 381
whose FR940405-1-00052 1 383
very FR940405-1-00052 2 392 1055
low FR940405-1-00052 1 393
natural FR940405-1-00052 1 394
there FR940405-1-00052 1 400
elevated FR940405-1-00052 1 403
risk FR940405-1-00052 2 404 410
relative FR940405-1-00052 1 409
= FR940405-1-00052 1 411
1.6 FR940405-1-00052 1 412
pets FR940405-1-00052 1 416
with FR940405-1-00052 7 417 838 876 934 991 1015 1027
analysis FR940405-1-00052 1 424
statistically FR940405-1-00052 1 426
insignificant FR940405-1-00052 1 427
perhaps FR940405-1-00052 1 429
part FR940405-1-00052 1 431
due FR940405-1-00052 1 432
small FR940405-1-00052 1 434
sample FR940405-1-00052 1 435
size FR940405-1-00052 1 436
7. FR940405-1-00052 1 438
genotoxicity FR940405-1-00052 3 439 522 751
shortterm FR940405-1-00052 3 440 485 514
mutagenicity FR940405-1-00052 3 441 486 679
tests FR940405-1-00052 3 442 462 487
gained FR940405-1-00052 1 444
widespread FR940405-1-00052 1 445
acceptance FR940405-1-00052 1 446
as FR940405-1-00052 5 447 571 573 932 1013
initial FR940405-1-00052 1 449
step FR940405-1-00052 1 450
identification FR940405-1-00052 1 453
carcinogens FR940405-1-00052 2 456 500
extensive FR940405-1-00052 1 458
use FR940405-1-00052 1 459
has FR940405-1-00052 2 463 492
come FR940405-1-00052 1 464
about FR940405-1-00052 1 465
they FR940405-1-00052 4 467 809 844 910
easy FR940405-1-00052 1 469
perform FR940405-1-00052 1 471
inexpensive FR940405-1-00052 1 474
reported FR940405-1-00052 3 480 494 734
high FR940405-1-00052 1 481
positive FR940405-1-00052 6 482 777 816 852 972 1000
correlations FR940405-1-00052 1 483
between FR940405-1-00052 1 484
it FR940405-1-00052 2 491 882
been FR940405-1-00052 4 493 517 580 733
that FR940405-1-00052 5 495 666 812 846 1051
90 FR940405-1-00052 2 496 505
percent FR940405-1-00052 2 497 506
tested FR940405-1-00052 2 501 612
mutagens FR940405-1-00052 2 503 1156
noncarcinogens FR940405-1-00052 1 509
nonmutagens FR940405-1-00052 1 511
several FR940405-1-00052 2 513 766
bioassays FR940405-1-00052 1 515
performed FR940405-1-00052 1 518
evaluate FR940405-1-00052 2 520 544
while FR940405-1-00052 1 527
them FR940405-1-00052 1 530
evaluated FR940405-1-00052 1 532
effect FR940405-1-00052 1 534
some FR940405-1-00052 1 540
attempted FR940405-1-00052 1 542
either FR940405-1-00052 2 545 703
gas FR940405-1-00052 1 547
phase FR940405-1-00052 1 548
or FR940405-1-00052 3 549 705 1028
commonly FR940405-1-00052 1 556
mutagenic FR940405-1-00052 8 560 584 604 649 710 737 943 1075
employs FR940405-1-00052 1 562
various FR940405-1-00052 1 563
strains FR940405-1-00052 2 564 782
salmonella FR940405-1-00052 4 566 586 780 945
typhimurium FR940405-1-00052 5 567 587 678 781 946
well FR940405-1-00052 1 572
shown FR940405-1-00052 1 581
be FR940405-1-00052 4 583 603 886 1036
strain FR940405-1-00052 6 588 654 806 947 966 1159
ta FR940405-1-00052 1 589
1538 FR940405-1-00052 1 590
421 FR940405-1-00052 1 594
found FR940405-1-00052 4 601 665 884 1034
system FR940405-1-00052 3 607 890 1040
where FR940405-1-00052 1 608
directly FR940405-1-00052 1 613
on FR940405-1-00052 1 614
bacterial FR940405-1-00052 2 616 653
plates FR940405-1-00052 1 617
4246 FR940405-1-00052 1 621
extracts FR940405-1-00052 1 627
ets FR940405-1-00052 1 629
collected FR940405-1-00052 2 630 1120
indoor FR940405-1-00052 1 632
air FR940405-1-00052 1 633
4202 FR940405-1-00052 1 637
45 FR940405-1-00052 1 639
4198 FR940405-1-00052 1 641
4201 FR940405-1-00052 1 643
4203 FR940405-1-00052 1 645
exhibited FR940405-1-00052 1 648
this FR940405-1-00052 5 652 889 940 1039 1088
claxton FR940405-1-00052 1 656
455 FR940405-1-00052 1 663
accounted FR940405-1-00052 1 669
approximately FR940405-1-00052 1 671
60 FR940405-1-00052 1 672
% FR940405-1-00052 3 673 684 692
total FR940405-1-00052 1 676
s. FR940405-1-00052 1 677
per FR940405-1-00052 1 680
40 FR940405-1-00052 1 683
particulates FR940405-1-00052 1 689
20 FR940405-1-00052 1 691
semis FR940405-1-00052 1 695
highly FR940405-1-00052 1 698
fraction FR940405-1-00052 1 700
both FR940405-1-00052 4 714 837 875 990
489 FR940405-1-00052 2 719 747
4193 FR940405-1-00052 1 721
490 FR940405-1-00052 2 729 904
doolittle FR940405-1-00052 2 740 897
demonstrated FR940405-1-00052 3 749 845 1073
kentucky FR940405-1-00052 2 758 924
reference FR940405-1-00052 2 759 925
1r4f FR940405-1-00052 2 762 929
employing FR940405-1-00052 1 765
different FR940405-1-00052 1 767
produced FR940405-1-00052 3 776 802 815
results FR940405-1-00052 4 778 804 817 1043
ta98 FR940405-1-00052 2 783 948
ta100 FR940405-1-00052 2 785 950
ta1537 FR940405-1-00052 2 787 952
ta1538 FR940405-1-00052 3 790 955 1160
presence FR940405-1-00052 2 793 958
s9 FR940405-1-00052 2 795 960
mix FR940405-1-00052 2 796 961
aroclorinduced FR940405-1-00052 1 798
liver FR940405-1-00052 1 800
negative FR940405-1-00052 2 803 964
ta1535 FR940405-1-00052 2 807 967
showed FR940405-1-00052 2 811 1150
chinese FR940405-1-00052 4 820 830 870 975
hamster FR940405-1-00052 4 821 831 871 976
ovary FR940405-1-00052 4 822 832 872 977
cells FR940405-1-00052 1 823
chromosomal FR940405-1-00052 1 824
aberration FR940405-1-00052 2 825 982
cell FR940405-1-00052 1 833
sisterchromatid FR940405-1-00052 1 834
exchange FR940405-1-00052 2 835 988
without FR940405-1-00052 4 840 878 993 1029
metabolic FR940405-1-00052 4 841 879 994 1030
activation FR940405-1-00052 4 842 880 995 1031
weakly FR940405-1-00052 2 851 999
inducing FR940405-1-00052 2 854 1002
dna FR940405-1-00052 2 855 1003
repair FR940405-1-00052 2 856 1004
cultured FR940405-1-00052 2 858 1006
hepatocytes FR940405-1-00052 2 860 1008
nonmutagenic FR940405-1-00052 2 867 1021
cellhgprt FR940405-1-00052 1 873
cytotoxic FR940405-1-00052 2 887 1037
further FR940405-1-00052 1 894
similar FR940405-1-00052 1 907
responses FR940405-1-00052 1 908
when FR940405-1-00052 1 909
measured FR940405-1-00052 1 911
genotoxic FR940405-1-00052 1 913
research FR940405-1-00052 1 926
cho FR940405-1-00052 1 979
cellschromosomal FR940405-1-00052 1 981
chosisterchromatid FR940405-1-00052 1 987
again FR940405-1-00052 1 1012
chohgprt FR940405-1-00052 1 1024
two FR940405-1-00052 2 1046 1104
appear FR940405-1-00052 1 1048
indicate FR940405-1-00052 1 1050
behaves FR940405-1-00052 1 1054
much FR940405-1-00052 1 1056
like FR940405-1-00052 1 1057
mohtashamipur FR940405-1-00052 1 1064
4227 FR940405-1-00052 1 1071
urine FR940405-1-00052 4 1079 1115 1140 1164
machine FR940405-1-00052 1 1093
smoked FR940405-1-00052 1 1094
under FR940405-1-00052 1 1095
standardized FR940405-1-00052 1 1096
laboratory FR940405-1-00052 1 1097
conditions FR940405-1-00052 1 1098
directed FR940405-1-00052 1 1107
through FR940405-1-00052 1 1108
metabolism FR940405-1-00052 1 1109
cages FR940405-1-00052 1 1110
containing FR940405-1-00052 1 1111
24 FR940405-1-00052 2 1121 1129
hours FR940405-1-00052 2 1122 1130
prior FR940405-1-00052 1 1123
onset FR940405-1-00052 1 1133
individual FR940405-1-00052 1 1139
samples FR940405-1-00052 2 1141 1165
10 FR940405-1-00052 1 1145
significantly FR940405-1-00052 1 1151
higher FR940405-1-00052 1 1152
directacting FR940405-1-00052 1 1155
than FR940405-1-00052 1 1162
same FR940405-1-00052 1 1168
before FR940405-1-00052 1 1170
the FR940405-1-00053 20 0 13 17 23 85 125 156 178 182 193 237 241 248 256 280 353 383 398 417 472
formation FR940405-1-00053 1 1
of FR940405-1-00053 21 2 19 64 100 106 177 185 201 215 234 243 279 283 305 333 343 385 401 416 460 471
dna FR940405-1-00053 8 3 20 34 86 120 166 176 244
adducts FR940405-1-00053 5 4 21 121 167 245
is FR940405-1-00053 1 5
widely FR940405-1-00053 2 6 395
accepted FR940405-1-00053 1 7
as FR940405-1-00053 3 8 29 255
an FR940405-1-00053 2 9 303
initial FR940405-1-00053 1 10
step FR940405-1-00053 1 11
in FR940405-1-00053 20 12 124 134 139 142 170 207 222 228 247 273 295 302 330 348 378 434 452 457 484
carcinogenesis FR940405-1-00053 1 14
process FR940405-1-00053 1 15
. FR940405-1-00053 30 16 41 45 48 82 108 117 129 145 165 189 192 217 236 266 276 310 313 338 341 363 376 404 410 437 441 444 469 486 510
measurement FR940405-1-00053 1 18
by FR940405-1-00053 3 22 493 498
32ppostlabeling FR940405-1-00053 1 24
assay FR940405-1-00053 2 25 380
has FR940405-1-00053 3 26 287 392
been FR940405-1-00053 4 27 271 288 393
used FR940405-1-00053 2 28 413
a FR940405-1-00053 4 30 277 414 430
way FR940405-1-00053 1 31
to FR940405-1-00053 11 32 38 54 155 162 181 263 290 396 463 504
assess FR940405-1-00053 1 33
damage FR940405-1-00053 1 35
following FR940405-1-00053 1 36
exposure FR940405-1-00053 7 37 101 118 202 216 235 481
cigarette FR940405-1-00053 8 39 285 316 354 359 402 421 464
smoke FR940405-1-00053 11 40 69 286 317 355 360 403 423 465 478 503
lee FR940405-1-00053 1 42
et FR940405-1-00053 2 43 439
al FR940405-1-00053 2 44 440
[ FR940405-1-00053 7 46 187 308 336 361 408 442
ex FR940405-1-00053 6 47 188 309 337 409 443
4194 FR940405-1-00053 1 49
] FR940405-1-00053 7 50 191 312 340 375 412 446
exposed FR940405-1-00053 4 51 154 180 462
spraguedawley FR940405-1-00053 1 52
rats FR940405-1-00053 1 53
0.1 FR940405-1-00053 1 55
, FR940405-1-00053 13 56 89 91 131 172 219 322 325 365 367 369 371 373
1 FR940405-1-00053 2 57 262
and FR940405-1-00053 13 58 66 93 97 102 174 203 299 326 406 424 479 508
10 FR940405-1-00053 2 59 264
mg FR940405-1-00053 2 60 265
total FR940405-1-00053 1 61
particulate FR940405-1-00053 1 62
matter/m3 FR940405-1-00053 1 63
aged FR940405-1-00053 1 65
diluted FR940405-1-00053 1 67
sidestream FR940405-1-00053 1 68
( FR940405-1-00053 2 70 388
adss FR940405-1-00053 3 71 186 257
) FR940405-1-00053 2 72 390
for FR940405-1-00053 5 73 78 114 160 466
6 FR940405-1-00053 1 74
hours FR940405-1-00053 1 75
per FR940405-1-00053 1 76
day FR940405-1-00053 1 77
14 FR940405-1-00053 3 79 98 104
consecutive FR940405-1-00053 1 80
days FR940405-1-00053 7 81 99 105 164 200 212 233
they FR940405-1-00053 2 83 109
examined FR940405-1-00053 2 84 111
from FR940405-1-00053 4 87 261 357 420
lung FR940405-1-00053 3 88 171 249
heart FR940405-1-00053 2 90 173
larynx FR940405-1-00053 2 92 175
liver FR940405-1-00053 1 94
after FR940405-1-00053 5 95 103 198 213 231
7 FR940405-1-00053 1 96
recovery FR940405-1-00053 1 107
also FR940405-1-00053 4 110 149 448 497
alveolar FR940405-1-00053 3 112 140 223
macrophages FR940405-1-00053 3 113 141 224
chromosomal FR940405-1-00053 3 115 135 220
aberrations FR940405-1-00053 3 116 136 221
related FR940405-1-00053 1 119
were FR940405-1-00053 7 122 148 153 168 196 204 225
found FR940405-1-00053 1 123
highest FR940405-1-00053 3 126 183 197
dose FR940405-1-00053 1 127
test FR940405-1-00053 1 128
however FR940405-1-00053 1 130
no FR940405-1-00053 1 132
elevation FR940405-1-00053 1 133
was FR940405-1-00053 3 137 259 346
observed FR940405-1-00053 1 138
this FR940405-1-00053 2 143 427
study FR940405-1-00053 1 144
similar FR940405-1-00053 1 146
results FR940405-1-00053 2 147 488
obtained FR940405-1-00053 1 150
when FR940405-1-00053 1 151
animals FR940405-1-00053 2 152 179
same FR940405-1-00053 1 157
three FR940405-1-00053 1 158
concentrations FR940405-1-00053 1 159
up FR940405-1-00053 1 161
90 FR940405-1-00053 4 163 199 211 232
seen FR940405-1-00053 1 169
concentration FR940405-1-00053 3 184 242 258
4195 FR940405-1-00053 1 190
adduct FR940405-1-00053 1 194
levels FR940405-1-00053 1 195
significantly FR940405-1-00053 1 205
reduced FR940405-1-00053 1 206
all FR940405-1-00053 1 208
target FR940405-1-00053 1 209
tissues FR940405-1-00053 1 210
cessation FR940405-1-00053 1 214
again FR940405-1-00053 1 218
not FR940405-1-00053 3 226 252 491
elevated FR940405-1-00053 1 227
any FR940405-1-00053 1 229
group FR940405-1-00053 1 230
authors FR940405-1-00053 1 238
concluded FR940405-1-00053 1 239
that FR940405-1-00053 5 240 381 426 476 500
formed FR940405-1-00053 1 246
tissue FR940405-1-00053 1 250
did FR940405-1-00053 1 251
increase FR940405-1-00053 2 253 433
linearly FR940405-1-00053 1 254
increased FR940405-1-00053 1 260
several FR940405-1-00053 2 267 349
shortterm FR940405-1-00053 1 268
tests FR940405-1-00053 1 269
have FR940405-1-00053 2 270 447
performed FR940405-1-00053 1 272
eukaryotic FR940405-1-00053 1 274
systems FR940405-1-00053 2 275 351
solution FR940405-1-00053 3 278 415 428
gas FR940405-1-00053 2 281 418
phase FR940405-1-00053 2 282 419
mainstream FR940405-1-00053 4 284 315 358 422
shown FR940405-1-00053 1 289
induce FR940405-1-00053 1 291
reciprocal FR940405-1-00053 2 292 327
mitotic FR940405-1-00053 3 293 319 328
recombination FR940405-1-00053 2 294 329
saccharomyces FR940405-1-00053 2 296 334
cerevisiae FR940405-1-00053 2 297 335
d3 FR940405-1-00053 2 298 307
petite FR940405-1-00053 1 300
mutants FR940405-1-00053 1 301
isolate FR940405-1-00053 1 304
strain FR940405-1-00053 2 306 331
4163 FR940405-1-00053 1 311
whole FR940405-1-00053 1 314
induced FR940405-1-00053 4 318 347 391 429
gene FR940405-1-00053 1 320
conversion FR940405-1-00053 1 321
reverse FR940405-1-00053 1 323
mutation FR940405-1-00053 1 324
d7 FR940405-1-00053 1 332
4113 FR940405-1-00053 1 339
transformation FR940405-1-00053 1 342
mammalian FR940405-1-00053 1 344
cells FR940405-1-00053 2 345 459
cell FR940405-1-00053 1 350
using FR940405-1-00053 1 352
condensate FR940405-1-00053 1 356
exs FR940405-1-00053 1 362
422 FR940405-1-00053 1 364
4161 FR940405-1-00053 1 366
4188 FR940405-1-00053 1 368
4267 FR940405-1-00053 1 370
4268 FR940405-1-00053 1 372
4298 FR940405-1-00053 1 374
another FR940405-1-00053 1 377
vitro FR940405-1-00053 1 379
measures FR940405-1-00053 1 382
number FR940405-1-00053 1 384
sisterchromatid FR940405-1-00053 2 386 435
exchanges FR940405-1-00053 2 387 436
sces FR940405-1-00053 1 389
employed FR940405-1-00053 1 394
determine FR940405-1-00053 1 397
mutagenic FR940405-1-00053 1 399
activity FR940405-1-00053 1 400
valadandberrieu FR940405-1-00053 1 405
izard FR940405-1-00053 1 407
4313 FR940405-1-00053 1 411
showed FR940405-1-00053 1 425
significant FR940405-1-00053 1 431
doserelated FR940405-1-00053 1 432
putman FR940405-1-00053 1 438
4257 FR940405-1-00053 1 445
demonstrated FR940405-1-00053 1 449
dosedependent FR940405-1-00053 1 450
increases FR940405-1-00053 1 451
sister FR940405-1-00053 1 453
chromatid FR940405-1-00053 1 454
exchange FR940405-1-00053 1 455
frequencies FR940405-1-00053 1 456
bonemarrow FR940405-1-00053 1 458
mice FR940405-1-00053 1 461
2 FR940405-1-00053 1 467
weeks FR940405-1-00053 1 468
review FR940405-1-00053 1 470
literature FR940405-1-00053 1 473
clearly FR940405-1-00053 1 474
demonstrates FR940405-1-00053 1 475
ms FR940405-1-00053 1 477
ets FR940405-1-00053 1 480
causes FR940405-1-00053 1 482
cancer FR940405-1-00053 1 483
humans FR940405-1-00053 1 485
these FR940405-1-00053 1 487
are FR940405-1-00053 1 489
supported FR940405-1-00053 1 490
only FR940405-1-00053 1 492
animal FR940405-1-00053 1 494
studies FR940405-1-00053 2 495 499
but FR940405-1-00053 1 496
show FR940405-1-00053 1 501
ss FR940405-1-00053 1 502
be FR940405-1-00053 1 505
both FR940405-1-00053 1 506
genotoxic FR940405-1-00053 1 507
clastogenic FR940405-1-00053 1 509
8. FR940405-1-00053 1 511
conclusions FR940405-1-00053 1 512
the FR940405-1-00054 46 0 99 190 213 216 218 260 310 317 368 371 525 530 553 556 569 573 579 593 606 618 625 683 688 697 708 720 744 754 770 774 788 813 816 835 852 857 870 877 886 909 917 926 938 941 946
epidemiological FR940405-1-00054 1 1
and FR940405-1-00054 29 2 29 57 73 130 183 204 287 313 333 380 407 429 437 443 456 661 667 672 741 779 807 828 830 895 905 912 934 943
clinical FR940405-1-00054 1 3
studies FR940405-1-00054 2 4 52
, FR940405-1-00054 54 5 9 22 24 26 28 50 119 123 129 141 148 151 176 201 203 222 266 268 270 272 274 276 278 280 282 284 286 316 330 332 338 340 342 346 350 382 412 430 433 440 453 501 522 548 576 659 715 722 802 825 827 902 904
taken FR940405-1-00054 1 6
in FR940405-1-00054 23 7 32 45 48 137 262 305 325 450 541 605 620 638 646 705 719 725 729 753 787 791 812 925
aggregate FR940405-1-00054 1 8
indicate FR940405-1-00054 1 10
that FR940405-1-00054 13 11 54 142 207 297 402 505 555 596 623 631 920 961
exposure FR940405-1-00054 3 12 35 87
to FR940405-1-00054 20 13 36 85 88 94 98 116 210 229 259 422 461 463 476 493 515 552 583 634 679
environmental FR940405-1-00054 1 14
tobacco FR940405-1-00054 3 15 59 233
smoke FR940405-1-00054 3 16 60 234
may FR940405-1-00054 2 17 38
produce FR940405-1-00054 2 18 61
mucous FR940405-1-00054 1 19
membrane FR940405-1-00054 1 20
irritation FR940405-1-00054 4 21 114 240 243
pulmonary FR940405-1-00054 2 23 41
cardiovascular FR940405-1-00054 2 25 43
reproductive FR940405-1-00054 1 27
carcinogenic FR940405-1-00054 1 30
effects FR940405-1-00054 8 31 64 111 115 256 321 474 637
nonsmokers FR940405-1-00054 2 33 46
. FR940405-1-00054 44 34 47 65 107 132 170 189 237 250 289 294 353 374 392 399 418 449 467 481 498 520 540 567 586 608 640 674 696 727 746 768 782 794 805 815 820 838 861 873 881 898 916 945 959
ets FR940405-1-00054 1 37
aggravate FR940405-1-00054 1 39
existing FR940405-1-00054 1 40
or FR940405-1-00054 5 42 241 424 693 845
disease FR940405-1-00054 2 44 128
addition FR940405-1-00054 1 49
animal FR940405-1-00054 1 51
show FR940405-1-00054 1 53
both FR940405-1-00054 1 55
mainstream FR940405-1-00054 1 56
sidestream FR940405-1-00054 1 58
similar FR940405-1-00054 3 62 252 472
adverse FR940405-1-00054 3 63 109 319
d. FR940405-1-00054 1 66
case FR940405-1-00054 2 67 77
reports FR940405-1-00054 3 68 78 616
1. FR940405-1-00054 1 69
sick FR940405-1-00054 5 70 167 357 417 564
building FR940405-1-00054 13 71 168 358 372 565 622 630 648 689 702 858 878 887
syndrome FR940405-1-00054 6 72 169 359 539 561 566
buildingrelated FR940405-1-00054 3 74 121 174
illness FR940405-1-00054 4 75 175 391 448
many FR940405-1-00054 2 76 419
of FR940405-1-00054 23 79 82 156 254 348 388 447 524 558 568 578 615 628 687 700 712 764 800 822 851 856 869 876
material FR940405-1-00054 1 80
impairment FR940405-1-00054 1 81
health FR940405-1-00054 10 83 110 255 320 473 484 545 636 641 676
due FR940405-1-00054 3 84 475 514
occupational FR940405-1-00054 1 86
poor FR940405-1-00054 4 89 477 600 626
iaq FR940405-1-00054 5 90 158 191 219 303
have FR940405-1-00054 10 91 172 180 322 395 458 486 508 533 550
been FR940405-1-00054 7 92 181 323 459 487 534 930
reported FR940405-1-00054 8 93 258 296 324 396 471 488 710
osha FR940405-1-00054 1 95
through FR940405-1-00054 1 96
submission FR940405-1-00054 1 97
indoor FR940405-1-00054 4 100 478 516 601
air FR940405-1-00054 6 101 405 479 517 602 814
quality FR940405-1-00054 4 102 480 518 603
docket FR940405-1-00054 3 103 138 263
[ FR940405-1-00054 10 104 144 231 292 397 731 737 748 757 890
h122 FR940405-1-00054 1 105
] FR940405-1-00054 9 106 146 235 401 733 739 750 759 892
these FR940405-1-00054 8 108 178 248 354 375 434 454 675
range FR940405-1-00054 1 112
from FR940405-1-00054 6 113 490 617 717 773 866
more FR940405-1-00054 2 117 482
severe FR940405-1-00054 3 118 451 491
lifethreatening FR940405-1-00054 1 120
illnesses FR940405-1-00054 1 122
such FR940405-1-00054 1 124
as FR940405-1-00054 3 125 166 404
legionnaire FR940405-1-00054 1 126
's FR940405-1-00054 2 127 386
cancer FR940405-1-00054 1 131
ford FR940405-1-00054 2 133 150
motor FR940405-1-00054 1 134
company FR940405-1-00054 2 135 308
responded FR940405-1-00054 2 136 504
comment FR940405-1-00054 6 139 291 469 502 610 918
3447 FR940405-1-00054 1 140
`` FR940405-1-00054 7 143 298 356 403 506 730 921
p FR940405-1-00054 1 145
resently FR940405-1-00054 1 147
at FR940405-1-00054 4 149 529 572 960
we FR940405-1-00054 3 152 171 193
investigate FR940405-1-00054 2 153 195
an FR940405-1-00054 2 154 797
average FR940405-1-00054 1 155
two FR940405-1-00054 2 157 312
complaints FR940405-1-00054 3 159 192 249
per FR940405-1-00054 1 160
month FR940405-1-00054 1 161
which FR940405-1-00054 1 162
are FR940405-1-00054 9 163 196 208 245 377 409 415 420 581
predominantly FR940405-1-00054 1 164
classified FR940405-1-00054 1 165
seen FR940405-1-00054 1 173
but FR940405-1-00054 1 177
incidents FR940405-1-00054 1 179
rare FR940405-1-00054 1 182
associated FR940405-1-00054 2 184 246
with FR940405-1-00054 4 185 247 536 543
specific FR940405-1-00054 1 186
contaminant FR940405-1-00054 1 187
episodes FR940405-1-00054 1 188
generally FR940405-1-00054 1 194
characterized FR940405-1-00054 1 197
by FR940405-1-00054 2 198 644
general FR940405-1-00054 1 199
malaise FR940405-1-00054 1 200
headache FR940405-1-00054 1 202
flulike FR940405-1-00054 1 205
symptoms FR940405-1-00054 4 206 364 376 446
said FR940405-1-00054 1 209
disappear FR940405-1-00054 2 211 366
when FR940405-1-00054 3 212 367 682
occupants FR940405-1-00054 1 214
leave FR940405-1-00054 1 215
building***of FR940405-1-00054 1 217
problems FR940405-1-00054 6 220 519 604 642 677 840
investigated FR940405-1-00054 1 221
about FR940405-1-00054 2 223 952
20 FR940405-1-00054 1 224
percent FR940405-1-00054 1 225
can FR940405-1-00054 2 226 632
be FR940405-1-00054 2 227 598
attributed FR940405-1-00054 1 228
pts FR940405-1-00054 1 230
passive FR940405-1-00054 1 232
/ets FR940405-1-00054 1 236
upper FR940405-1-00054 2 238 464
respiratory FR940405-1-00054 2 239 465
eye FR940405-1-00054 3 242 329 658
typically FR940405-1-00054 1 244
'' FR940405-1-00054 6 251 363 393 468 609 769
types FR940405-1-00054 1 253
were FR940405-1-00054 8 257 562 685 723 810 818 841 864
agency FR940405-1-00054 1 261
comments FR940405-1-00054 1 264
31 FR940405-1-00054 1 265
322 FR940405-1-00054 1 267
358 FR940405-1-00054 1 269
3142c FR940405-1-00054 1 271
3367 FR940405-1-00054 1 273
3413 FR940405-1-00054 1 275
3529 FR940405-1-00054 1 277
3632 FR940405-1-00054 1 279
3634 FR940405-1-00054 1 281
3642 FR940405-1-00054 1 283
3659 FR940405-1-00054 1 285
3698 FR940405-1-00054 1 288
one FR940405-1-00054 2 290 621
ex FR940405-1-00054 2 293 398
3433 FR940405-1-00054 1 295
based FR940405-1-00054 1 299
upon FR940405-1-00054 1 300
approximately FR940405-1-00054 1 301
30 FR940405-1-00054 1 302
investigations FR940405-1-00054 1 304
a FR940405-1-00054 11 306 384 389 510 613 629 691 694 761 792 922
member FR940405-1-00054 1 307
over FR940405-1-00054 2 309 690
past FR940405-1-00054 1 311
onehalf FR940405-1-00054 1 314
years FR940405-1-00054 2 315 933
following FR940405-1-00054 1 318
office FR940405-1-00054 5 326 532 575 607 836
environments FR940405-1-00054 1 327
: FR940405-1-00054 1 328
nose FR940405-1-00054 2 331 660
throat FR940405-1-00054 2 334 662
irritations FR940405-1-00054 3 335 442 663
; FR940405-1-00054 9 336 344 428 653 655 657 664 669 671
headaches FR940405-1-00054 2 337 654
nausea FR940405-1-00054 2 339 439
dizziness FR940405-1-00054 1 341
fatigue FR940405-1-00054 4 343 538 560 656
cough FR940405-1-00054 1 345
shortness FR940405-1-00054 1 347
breath FR940405-1-00054 1 349
chest FR940405-1-00054 1 351
tightness FR940405-1-00054 1 352
socalled FR940405-1-00054 1 355
( FR940405-1-00054 1 360
sbs FR940405-1-00054 1 361
) FR940405-1-00054 1 362
often FR940405-1-00054 1 365
person FR940405-1-00054 1 369
leaves FR940405-1-00054 1 370
environment FR940405-1-00054 1 373
usually FR940405-1-00054 1 378
subjective FR940405-1-00054 1 379
nonc FR940405-1-00054 1 381
lacking FR940405-1-00054 1 383
physician FR940405-1-00054 1 385
diagnosis FR940405-1-00054 1 387
definite FR940405-1-00054 1 390
others FR940405-1-00054 1 394
3377 FR940405-1-00054 1 400
flow FR940405-1-00054 1 406
ventilation FR940405-1-00054 3 408 432 839
cut FR940405-1-00054 1 410
back FR940405-1-00054 2 411 914
our FR940405-1-00054 1 413
workers FR940405-1-00054 6 414 619 639 645 684 899
becoming FR940405-1-00054 1 416
exposed FR940405-1-00054 1 421
contaminants FR940405-1-00054 2 423 455
other FR940405-1-00054 4 425 444 594 831
harmful FR940405-1-00054 1 426
substances FR940405-1-00054 1 427
without FR940405-1-00054 1 431
sources FR940405-1-00054 1 435
linger FR940405-1-00054 1 436
cause FR940405-1-00054 1 438
skin FR940405-1-00054 1 441
unhealthy FR940405-1-00054 1 445
cases FR940405-1-00054 1 452
bacteria FR940405-1-00054 1 457
known FR940405-1-00054 1 460
contribute FR940405-1-00054 1 462
infections FR940405-1-00054 2 466 652
3570 FR940405-1-00054 1 470
serious FR940405-1-00054 3 483 511 635
conditions FR940405-1-00054 2 485 627
ranging FR940405-1-00054 1 489
asthma FR940405-1-00054 3 492 512 673
central FR940405-1-00054 1 494
nervous FR940405-1-00054 1 495
systems FR940405-1-00054 1 496
disorders FR940405-1-00054 1 497
for FR940405-1-00054 4 499 893 932 951
example FR940405-1-00054 1 500
3158 FR940405-1-00054 1 503
i FR940405-1-00054 2 507 549
developed FR940405-1-00054 1 509
condition FR940405-1-00054 2 513 699
besides FR940405-1-00054 1 521
three FR940405-1-00054 1 523
remaining FR940405-1-00054 1 526
five FR940405-1-00054 1 527
employees FR940405-1-00054 2 528 571
branch FR940405-1-00054 2 531 574
diagnosed FR940405-1-00054 1 535
chronic FR940405-1-00054 3 537 559 650
conversations FR940405-1-00054 1 542
various FR940405-1-00054 1 544
care FR940405-1-00054 1 546
professionals FR940405-1-00054 1 547
come FR940405-1-00054 1 551
conclusion FR940405-1-00054 1 554
diagnoses FR940405-1-00054 1 557
actually FR940405-1-00054 1 563
six FR940405-1-00054 2 570 580
four FR940405-1-00054 1 577
moderate FR940405-1-00054 1 582
heavy FR940405-1-00054 1 584
smokers FR940405-1-00054 1 585
this FR940405-1-00054 3 587 647 701
does FR940405-1-00054 1 588
not FR940405-1-00054 1 589
take FR940405-1-00054 1 590
into FR940405-1-00054 1 591
consideration FR940405-1-00054 1 592
factors FR940405-1-00054 1 595
could FR940405-1-00054 1 597
causing FR940405-1-00054 1 599
3631 FR940405-1-00054 1 611
was FR940405-1-00054 7 612 703 796 859 879 888 957
collection FR940405-1-00054 1 614
illustrate FR940405-1-00054 1 624
lead FR940405-1-00054 1 633
experienced FR940405-1-00054 1 643
included FR940405-1-00054 1 649
sinus FR940405-1-00054 1 651
difficulty FR940405-1-00054 1 665
breathing FR940405-1-00054 1 666
congestion FR940405-1-00054 1 668
allergies FR940405-1-00054 1 670
seem FR940405-1-00054 1 678
clear FR940405-1-00054 1 680
up FR940405-1-00054 1 681
out FR940405-1-00054 2 686 790
weekend FR940405-1-00054 1 692
vacation FR940405-1-00054 1 695
physical FR940405-1-00054 2 698 854
obviously FR940405-1-00054 1 704
disrepair FR940405-1-00054 1 706
since FR940405-1-00054 2 707 843
commenters FR940405-1-00054 1 709
pails FR940405-1-00054 3 711 735 755
stagnant FR940405-1-00054 1 713
water FR940405-1-00054 7 714 728 771 780 783 935 947
collected FR940405-1-00054 1 716
leaks FR940405-1-00054 2 718 772
roof FR940405-1-00054 3 721 775 872
left FR940405-1-00054 2 724 752
hallways FR940405-1-00054 1 726
t FR940405-1-00054 1 732
hese FR940405-1-00054 1 734
ha FR940405-1-00054 1 736
d FR940405-1-00054 2 738 758
overflowed FR940405-1-00054 1 740
run FR940405-1-00054 1 742
down FR940405-1-00054 1 743
stairs FR940405-1-00054 2 745 915
what FR940405-1-00054 2 747 767
wa FR940405-1-00054 1 749
s FR940405-1-00054 1 751
evaporate FR940405-1-00054 1 756
leaving FR940405-1-00054 1 760
gross FR940405-1-00054 1 762
residue FR940405-1-00054 1 763
who FR940405-1-00054 1 765
knows FR940405-1-00054 1 766
caused FR940405-1-00054 1 776
mold FR940405-1-00054 2 777 826
infestation FR940405-1-00054 2 778 875
damage FR940405-1-00054 1 781
logged FR940405-1-00054 1 784
insulation FR940405-1-00054 1 785
hung FR940405-1-00054 1 786
ceiling FR940405-1-00054 1 789
hallway FR940405-1-00054 1 793
there FR940405-1-00054 1 795
obvious FR940405-1-00054 1 798
lack FR940405-1-00054 1 799
routine FR940405-1-00054 1 801
sufficient FR940405-1-00054 1 803
cleaning FR940405-1-00054 1 804
dust FR940405-1-00054 1 806
particulate FR940405-1-00054 1 808
matter FR940405-1-00054 1 809
visible FR940405-1-00054 1 811
bathrooms FR940405-1-00054 1 817
dirty FR940405-1-00054 1 819
smells FR940405-1-00054 1 821
sewer FR940405-1-00054 1 823
gas FR940405-1-00054 1 824
diesel FR940405-1-00054 1 829
vehicular FR940405-1-00054 1 832
fumes FR940405-1-00054 4 833 847 863 883
permeated FR940405-1-00054 1 834
space FR940405-1-00054 1 837
evident FR940405-1-00054 3 842 865 880
paint FR940405-1-00054 1 844
varnish FR940405-1-00054 1 846
lingered FR940405-1-00054 2 848 884
whenever FR940405-1-00054 2 849 885
part FR940405-1-00054 1 850
inside FR940405-1-00054 1 853
structure FR940405-1-00054 1 855
painted FR940405-1-00054 1 860
tar FR940405-1-00054 1 862
constant FR940405-1-00054 1 867
patching FR940405-1-00054 1 868
leaky FR940405-1-00054 1 871
insect FR940405-1-00054 1 874
pesticide FR940405-1-00054 1 882
spray FR940405-1-00054 1 889
ed FR940405-1-00054 1 891
roaches FR940405-1-00054 1 894
steam FR940405-1-00054 2 896 906
bugs FR940405-1-00054 2 897 907
sighted FR940405-1-00054 1 900
cockroaches FR940405-1-00054 1 901
silverfish FR940405-1-00054 1 903
near FR940405-1-00054 1 908
coffee FR940405-1-00054 1 910
shop FR940405-1-00054 1 911
on FR940405-1-00054 2 913 937
continued FR940405-1-00054 1 919
sink FR940405-1-00054 1 923
faucet FR940405-1-00054 1 924
lunch FR940405-1-00054 1 927
room FR940405-1-00054 1 928
has FR940405-1-00054 1 929
leaking FR940405-1-00054 1 931
runs FR940405-1-00054 1 936
counter FR940405-1-00054 1 939
under FR940405-1-00054 1 940
toaster FR940405-1-00054 1 942
microwave FR940405-1-00054 1 944
heater FR940405-1-00054 1 948
had FR940405-1-00054 1 949
leaked FR940405-1-00054 1 950
2 FR940405-1-00054 1 953
months FR940405-1-00054 1 954
before FR940405-1-00054 1 955
it FR940405-1-00054 1 956
fixed FR940405-1-00054 1 958
time FR940405-1-00054 1 962
